GERMANY –CureVac and GlaxoSmithKline have signed on to a German pandemic contingency plan to reserve mRNA production capacity for years to come as they take another stab at a second-generation…
Read MoreTag: CureVac
CureVac’s vaccine proves to have a 47% efficacy rating after its preliminary results
EUROPE – The German company CureVac provided disappointing preliminary results from a clinical trial of its COVID-19 vaccine, dimming hopes that it could help fill the world’s current greatest need.…
Read More